Comparative Effectiveness and Safety of Oral Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction: A Systematic Review and Network Meta-analysis
Publication in refereed journal


Times Cited
Web of Science112WOS source URL (as at 29/05/2020) Click here for the latest count
Altmetrics Information
.

Other information
AbstractContext: Phosphodiesterase type 5 inhibitors (PDE5-Is) are currently the first-line therapy for erectile dysfunction (ED), but available studies investigating the comparative effects of different PDE5-Is are limited.
All Author(s) ListYuan JQ, Zhang RJ, Yang ZY, Lee J, Liu YL, Tian JH, Qin XW, Ren ZJ, Ding H, Chen Q, Mao C, Tang JL
Journal nameEuropean Urology
Year2013
Month5
Day1
Volume Number63
Issue Number5
PublisherELSEVIER SCIENCE BV
Pages902 - 912
ISSN0302-2838
eISSN1873-7560
LanguagesEnglish-United Kingdom
KeywordsErectile dysfunction; Network meta-analysis; Phosphodiesterase type 5 inhibitors; Systematic review
Web of Science Subject CategoriesUrology & Nephrology; UROLOGY & NEPHROLOGY

Last updated on 2020-30-05 at 02:31